International Journal of Computational and Theoretical Chemistry

Submit a Manuscript

Publishing with us to make your research visible to the widest possible audience.

Propose a Special Issue

Building a community of authors and readers to discuss the latest research and develop new ideas.

Theoretical Study on the Stereo Electronic Interactions of Busulfan Anti-cancer Drug with Modified Nano Cellulose Surface

In this study, the interaction of Busulfan anticancer drug with PEG-modified cellulose was investigated. The impacts of the stereo electronic effect associated with donor-acceptor electron delocalizations, dipole-dipole interactions, and total steric exchange energies on the structural and electronic properties and reactivity of modified cellulose in interaction with Busulfan anticancer drug was studied based on the Density Functional Theory (DFT) calculations by using B3LYP/(6-31G, 6-31G*) level of theory in the gas phase, and water solution. Thermodynamic functional analysis indicates that the relative energies (ΔE), free Gibbs energies (ΔG) and enthalpies (ΔH) are negative for of Busulfan anticancer drug-PEG-modified cellulose system, but the calculated entropies (ΔS) are Positive, suggesting thermodynamic favorability for covalent attachment of dye on PEG-modified cellulose and these results confirm the structural stability of the Busulfan in gas phases. Delocalization of charge density between the bonding or lone pair and antibonding orbitals calculated by NBO (natural bond orbital) analysis. The calculated LUMO-HOMO energy bond gap shows that charge density transfer occurs within the molecules and the semi-conductivity of PEG could be justified. Also, based on the parameters obtained for the Busulfan drug in the absence of cellulose, it can be said that due to the presence of cellulose, the interaction between the electronegative oxygen atom of cellulose and the carbons of Busulfan has the least electron coverage and is more affected by the external magnetic field, so They have the lowest σiso and the highest δ or chemical shift, but in the absence of cellulose, carbon does not interact with oxygen, it has the highest electron coverage and appears in the 13CNMR spectrum at a lower δ chemical shift.

Cellulose, PEG, Thermodynamic Functional, Delocalization

APA Style

Mohammad Rizehbandi, Maryam Ariannezhad. (2022). Theoretical Study on the Stereo Electronic Interactions of Busulfan Anti-cancer Drug with Modified Nano Cellulose Surface. International Journal of Computational and Theoretical Chemistry, 10(2), 14-20. https://doi.org/10.11648/j.ijctc.20221002.11

ACS Style

Mohammad Rizehbandi; Maryam Ariannezhad. Theoretical Study on the Stereo Electronic Interactions of Busulfan Anti-cancer Drug with Modified Nano Cellulose Surface. Int. J. Comput. Theor. Chem. 2022, 10(2), 14-20. doi: 10.11648/j.ijctc.20221002.11

AMA Style

Mohammad Rizehbandi, Maryam Ariannezhad. Theoretical Study on the Stereo Electronic Interactions of Busulfan Anti-cancer Drug with Modified Nano Cellulose Surface. Int J Comput Theor Chem. 2022;10(2):14-20. doi: 10.11648/j.ijctc.20221002.11

Copyright © 2022 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. Reverchon, E. Adami, R. (2006). Nanomaterials and supercritical fluids. The Journal of supercritical fluids, 37 (1), 1-22.
2. Vrána, A. Andrysek, T. (2001). The effect of particle size on bioavailability in cyclosporine preparations based on submicron dispersions. biomedical papers-palacky university in Olomouc, 145 (2), 9–15.
3. Nishihata, T. Ishizaka, M. Yokohama, S. Martino, A. C. Gordon, R. E. (1993). Effects of Particle Size of Bulk Drug and food on the Bioavailability of U-78875 in Dogs. Drug development and industrial pharmacy, 19 (20), 2679–2698.
4. Lashkarbolooki, M. Vaezian, A. Hezave, A. Z. Ayatollahi, S. Riazi, M. (2016). Experimental investigation of the influence of supercritical carbon dioxide and supercritical nitrogen injection on tertiary live-oil recovery. The Journal of Supercritical Fluids, 117, 260–269.
5. Kalani, M. Yunus, R. (2011). Application of supercritical antisolvent method in drug encapsulation: a review. International journal of nanomedicine, 6, 1429-1442.
6. Hezave, A. Z. Esmaeilzadeh, F. (2010). Crystallization of micro particles of sulindac using rapid expansion of supercritical solution. Journal of Crystal Growth, 12 (22), 3373-3383.
7. Hezave, A. Z. Esmaeilzadeh, F. (2010). Micronization of drug particles via RESS process. The Journal of Supercritical Fluids, 52 (1), 84-98.
8. Catchpole, O. J. Hochmann, S. Anderson, S. R. J. (1996). Gas anti-solvent fractionation of natural products. in Process Technology Proceedings, 1, 309–314.
9. Dehghani, F. Foster, N. R. (2003). Dense gas anti-solvent processes for pharmaceutical formulation. Current Opinion in Solid State and Materials Science, 7 (4-5), 363-9.
10. Imchalee, R. Charoenchaitrakool, M. (2015). Gas anti-solvent processing of a new sulfamethoxazole− l-malic acid cocrystal. Journal of Industrial and Engineering Chemistry, 25, 12–15.
11. Foster, N. R. Kurniawansyah, F. Tandya, A. Delgado, C. Mammucari, R. (2017). Particle processing by dense gas antisolvent precipitation: ARISE scale-up. Chemical Engineering Journal, 308, 535–543.
12. Kurniawansyah, F. Mammucari, R. Foster, N. R. (2017). Polymorphism of curcumin from dense gas antisolvent precipitation. Powder Technology, 305, 748–756.
13. Xie, F. Gu, J. (2019). Computational methods and applications for quantitative systems pharmacology. Quantitative Biology, 7, 3–16.
14. Jarada, T. N. Rokne, J. G. Alhajj, R. (2021). SNF–CVAE: computational method to predict drug–disease interactions using similarity network fusion and collective variational autoencoder. Knowledge-Based Systems, 212, 106585.
15. Sliwoski, G. Kothiwale, S. Meiler, J. Lowe, E. W. (2014). Computational methods in drug discovery. Pharmacological reviews, 66 (1), 334–395.
16. Jamal, S. B. Naz, S. Khan, R. Haider, A. Raza R. Z, Abbasi, S. W. (2020). Computational Methods in Road towards Drug Discovery against SARS-CoV2. Life and Science, 1, 6.
17. Khandeparkar, A. Rataboli, P. V. (2017). A study of harmful drug–drug interactions due to polypharmacy in hospitalized patients in Goa Medical College. Perspectives in clinical research, 8 (4), 180.
18. Neuman, M. G. (2020). Hepatotoxicity: mechanisms of liver injury. InLiver Diseases, 75-84.
19. Koay E. J, Owen D, Das P. (2018). Radiation-induced liver disease and modern radiotherapy. InSeminars in radiation oncology, 28 (4), 321-331.
20. Sharma, A. Houshyar, R. Bhosale, P. Choi, J. I. Gulati, R. Lall, C. (2014). Chemotherapy induced liver abnormalities: an imaging perspective. Clinical and molecular hepatology, 20 (3). 317-326.
21. Dasari, S. Tchounwou, P. B. (2014). Cisplatin in cancer therapy: molecular mechanisms of action. European journal of pharmacology, 740, 364-378.
22. Rodriguez-Galindo, C. Spunt, S. L. Pappo, A. S. (2003). Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Medical and pediatric oncology, 40 (5), 276–287.
23. Lanvers-Kaminsky, C. Bremer, A. Dirksen, U. Jürgens, H. (2006). Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines. Anti-cancer drugs, 17 (6), 657–662.
24. Iwamoto, T. Hiraku, Y. Oikawa, S. Mizutani, H. Kojima, M. Kawanishi, S. (2004). DNA intrastrand cross-link at the 5′-GA-3′ sequence formed by busulfan and its role in the cytotoxic effect. Cancer science, 95 (5), 454–458.
25. Missailidis, S. (2008). Anticancer therapeutics. John Wiley & Sons.
26. Karthick, T. Tandon, P. (2016). Computational approaches to find the active binding sites of biological targets against busulfan. Journal of molecular modeling, 22 (6), 1–9.
27. McKenna, R. Neidle, S. Kuroda, R. Fox, B. W. (1989). Structures of three DNA cross-linking agents, ethane-1, 2-di (methylsulfonate), propane-1, 3-di (methylsulfonate) and n-butane-1, 4-di (methylsulfonate). Acta Crystallographica Section C: Crystal Structure Communications, 45 (2), 311–314.
28. Garcia-Perez, L. van Roon, L. Schilham, M. W. Lankester, A. C. Pike-Overzet, K. Staal, F. J. (2021). Combining mobilizing agents with busulfan to reduce chemotherapy-based conditioning for hematopoietic stem cell transplantation. Cells, 10 (5), 1077.
29. Chen, X. Liang, M. Wang, (2018). Progress on the study of the mechanism of busulfan cytotoxicity. Cytotechnology, 70 (2), 497–502.
30. Hao, C. Ma, X. Wang, L. Zhang, W. Hu, J. Huang, J. Yang, W. (2021). Predicting the presence and mechanism of busulfan drug-drug interactions in hematopoietic stem cell transplantation using pharmacokinetic interaction network–based molecular structure similarity and network pharmacology. European Journal of Clinical Pharmacology, 77 (4), 595–605.